Amalgamated Bank’s HilleVax HLVX Stock Holding History

Amalgamated Bank’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-891	Closed	-$1K	–	3061
2025 Q1	$1K	Hold	891	–	–	﹤0.01%	2912
2024 Q4	$2K	Hold	891	–	–	﹤0.01%	2902
2024 Q3	$2K	Hold	891	–	–	﹤0.01%	2933
2024 Q2	$13K	Hold	891	–	–	﹤0.01%	2304
2024 Q1	$15K	Sell	891 -1,109	-55%	-$17.7K	﹤0.01%	2259
2023 Q4	$32K	Sell	2,000 -189	-9%	-$2.51K	﹤0.01%	2435
2023 Q3	$29K	Hold	2,189	–	–	﹤0.01%	2479
2023 Q2	$38K	Buy	2,189 +220	+11%	+$3.41K	﹤0.01%	2434
2023 Q1	$33K	Sell	1,969 -96	-5%	-$1.54K	﹤0.01%	2468
2022 Q4	$35K	Buy	2,065 +337	+20%	+$6.08K	﹤0.01%	2576
2022 Q3	$30K	Buy	1,728 +6	+0.3%	+$87	﹤0.01%	2673
2022 Q2	$19K	Buy	+1,722	New	+$20.4K	﹤0.01%	2870

Other funds holding HLVX

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

LMC

Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Amalgamated Bank's HLVX Position: Q2 2025 in Review

Amalgamated Bank sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 891 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in HLVX in Q2 2022 and held it in 12 quarters. The position peaked at $38K in Q2 2023. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

Amalgamated Bank reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 891 HilleVax shares in Q2 2025, an estimated $1K.
Amalgamated Bank first reported a position in HilleVax in Q2 2022 and held it in 12 quarters.
Amalgamated Bank's HilleVax position peaked at $38K in Q2 2023.
74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.